Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04682223 · ClinicalTrials.gov registry record · NA

Telerehabilitation for Aphasia (TERRA)

A NA study of Stroke and Aphasia, sponsored by University of South Carolina.

Recruiting
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT04682223 is a NA study of Stroke and Aphasia that is actively recruiting participants, run by University of South Carolina. The registered enrollment target is 100 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04682223, a NA study of Stroke and Aphasia, is actively recruiting participants, sponsored by University of South Carolina.

RECRUITING
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

Speech-language therapy is generally found to be helpful in the rehabilitation of aphasia. However, not all patients with aphasia have access to adequate treatment to maximize their recovery. The goal of this project is to compare the efficacy of telerehabilitation or Aphasia Remote Therapy (ART) to the more traditional In-Clinic Therapy (I-CT).

Interventions

  • BEHAVIORAL Semantically-focused therapy tasks
  • BEHAVIORAL Phonologically-focused therapy tasks

Study Locations (1)

South Carolina

  • University of South Carolina Aphasia Lab - Columbia

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2021-05-05
Est. Completion 2026-03-31
Phase NA

Sponsor

University of South Carolina

157 total trials

What the Registry Record Tells You About NCT04682223

The ClinicalTrials.gov registry entry for NCT04682223 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (99% lower). The listed sponsor is University of South Carolina, which has 157 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Stroke appearing as the primary indexed condition, and to 2 interventions - of which Semantically-focused therapy tasks is the first listed.

NCT04682223 reports 1 study location spanning 1 distinct geographic area - top geographies include South Carolina.

Frequently Asked Questions

What is clinical trial NCT04682223 about?

NCT04682223 is a clinical study titled "Telerehabilitation for Aphasia (TERRA)". Speech-language therapy is generally found to be helpful in the rehabilitation of aphasia. However, not all patients with aphasia have access to adequate treatment to maximize their recovery. The goal of this project is to compare the efficacy of telerehabilitation or Aphasia Remote Therapy (ART) to...

What is the current status of trial NCT04682223?

This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2021-05-05. Estimated completion is 2026-03-31.

What conditions does trial NCT04682223 study?

This clinical trial studies the following conditions: Stroke, Aphasia, Stroke Rehabilitation.

What interventions are being tested in trial NCT04682223?

The interventions under investigation include: Semantically-focused therapy tasks (BEHAVIORAL), Phonologically-focused therapy tasks (BEHAVIORAL).

Who is sponsoring clinical trial NCT04682223?

This trial is sponsored by University of South Carolina, which has 157 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04682223 being conducted?

This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.